RU2001131215A - Pharmaceutical composition for the treatment of fungal diseases - Google Patents

Pharmaceutical composition for the treatment of fungal diseases

Info

Publication number
RU2001131215A
RU2001131215A RU2001131215/14A RU2001131215A RU2001131215A RU 2001131215 A RU2001131215 A RU 2001131215A RU 2001131215/14 A RU2001131215/14 A RU 2001131215/14A RU 2001131215 A RU2001131215 A RU 2001131215A RU 2001131215 A RU2001131215 A RU 2001131215A
Authority
RU
Russia
Prior art keywords
treatment
pharmaceutical composition
fungal diseases
griseofulvin
pvp
Prior art date
Application number
RU2001131215/14A
Other languages
Russian (ru)
Other versions
RU2223093C2 (en
Inventor
Светлана Александровна Еремкина
Нина Алексеевна Аришина
Original Assignee
Открытое акционерное общество "Биосинтез"
Filing date
Publication date
Application filed by Открытое акционерное общество "Биосинтез" filed Critical Открытое акционерное общество "Биосинтез"
Priority to RU2001131215/15A priority Critical patent/RU2223093C2/en
Priority claimed from RU2001131215/15A external-priority patent/RU2223093C2/en
Publication of RU2001131215A publication Critical patent/RU2001131215A/en
Application granted granted Critical
Publication of RU2223093C2 publication Critical patent/RU2223093C2/en

Links

Claims (1)

Фармацевтическая композиция для лечения грибковых заболеваний, содержащая активное вещество и фармацевтически приемлемые целевые добавки, отличающаяся тем, что в качестве активного вещества она содержит гризеофульвин и в качестве целевых добавок - сахар молочный, крахмал картофельный, кальция стеарат, поливинилпирролидон низкомолекулярный (ПВП) при следующем соотношении ингредиентов, г:A pharmaceutical composition for the treatment of fungal diseases containing an active substance and pharmaceutically acceptable target additives, characterized in that it contains griseofulvin as the active substance and milk sugar, potato starch, calcium stearate, low molecular weight polyvinylpyrrolidone (PVP) as the following additives in the following ratio ingredients, g: Гризеофульвин 0,12888Griseofulvin 0.12888 Кальция стеарат 0,00180Calcium Stearate 0.00180 Сахар молочный 0,02472Milk sugar 0.02472 ПВП 0,00320-0,00430PVP 0.00320-0.00430 Крахмал картофельный 0,02030-0,02140Potato starch 0.02030-0.02140
RU2001131215/15A 2001-11-19 2001-11-19 Pharmaceutical composition for fungal disease treatment RU2223093C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2001131215/15A RU2223093C2 (en) 2001-11-19 2001-11-19 Pharmaceutical composition for fungal disease treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2001131215/15A RU2223093C2 (en) 2001-11-19 2001-11-19 Pharmaceutical composition for fungal disease treatment

Publications (2)

Publication Number Publication Date
RU2001131215A true RU2001131215A (en) 2003-07-10
RU2223093C2 RU2223093C2 (en) 2004-02-10

Family

ID=32172148

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001131215/15A RU2223093C2 (en) 2001-11-19 2001-11-19 Pharmaceutical composition for fungal disease treatment

Country Status (1)

Country Link
RU (1) RU2223093C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2744142C1 (en) * 2019-12-06 2021-03-03 Общество с ограниченной ответственностью "Артлайф" Composition for prevention of fungal diseases

Similar Documents

Publication Publication Date Title
FR11C0017I2 (en) Use of spinosad or a formulation comprising spinosad
CA2326756A1 (en) Pharmaceutical compositions containing compounds with activity for the enhancement of absorption of active ingredients
WO1998009597A3 (en) Cushioning beads and tablet comprising the same capable of forming a suspension
EP2322146A3 (en) Microcapsule formulations comprising two pharmaceutically active ingredients
EP1783126A3 (en) N-oxides of N-phenyl-2-pyrimidine-amine derivatives
CA2321523A1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
ATE332138T1 (en) FLIBANSERIN FOR THE TREATMENT OF EXTRAPYRAMIDAL MOTION DISORDERS
HRP20050342B1 (en) Pharmaceutical formulation of olanzapine
RU2003100507A (en) PHARMACEUTICAL COMPOSITIONS
CA2423574A1 (en) Stabilization of solid drug formulations
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
CA2340734A1 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
RU2001131215A (en) Pharmaceutical composition for the treatment of fungal diseases
CA2457982A1 (en) Use of nefiracetam for treating neurodegeneration
CA2429793A1 (en) Interferon therapeutic effect enhancer
RU2002125813A (en) ANTIBACTERIAL MEANS
RU2002119319A (en) Antibacterial pharmaceutical composition
RU2000115604A (en) COMPOSITION OF ANTIBACTERIAL MEDICINE
RU2003111436A (en) THE PREPARATION "WILL PREPARE WITH VITAMIN C" Possessing ANTI-INFLAMMATORY AND ANTI-MICROBIAL PROPERTIES
RU2003115414A (en) BIOLOGICALLY ACTIVE PREPARATION "ENTEROMIXIN"
RU2004104603A (en) ANTIFUNGAL PHARMACEUTICAL COMPOSITION
RU2001113338A (en) The drug for the treatment of bees
RU2000113775A (en) PREPARATION AND TREATMENT OF ENDOMETRITIS
RU2002124643A (en) BIOLOGICALLY ACTIVE ADDITIVE "VITAMIN FLOWER"
CA2099585A1 (en) Pharmaceutical compositions